• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响中国老年人带状疱疹疫苗接种的因素:一项离散选择实验的结果。

Factors influencing herpes zoster vaccination among older people in China: results from a discrete choice experiment.

机构信息

Zhejiang Chinese Medical University, 548 Binwen Road, Binjiang District, Hangzhou, Zhejiang, 310053, China.

Zhejiang Chinese Medical University, 548 Binwen Road, Binjiang District, Hangzhou, Zhejiang, 310053, China.

出版信息

Public Health. 2023 Jul;220:33-34. doi: 10.1016/j.puhe.2023.04.025. Epub 2023 May 30.

DOI:10.1016/j.puhe.2023.04.025
PMID:37263175
Abstract

OBJECTIVES

Vaccination is the most effective way to prevent herpes zoster (HZ) and related complications. This study aimed to investigate the preference of HZ vaccine among older people.

STUDY DESIGN

A discrete choice experiment was performed.

METHODS

In total, 178 adults aged ≥50 years were invited to choose between HZ vaccination scenarios using six vaccine attributes. Two equations were used to calculate participants' willingness to pay for the vaccine and their predicted choice probability.

RESULTS

The attributes that significantly influenced participants' vaccine choices were lower cost, higher effectiveness, reduced side-effects and vaccination of others in their surroundings.

CONCLUSIONS

Improving medical insurance coverage or reducing the cost of the HZ vaccine will encourage more people to be vaccinated, resulting in reduced burden of disease among older people.

摘要

目的

接种疫苗是预防带状疱疹(HZ)及相关并发症的最有效方法。本研究旨在调查老年人对 HZ 疫苗的偏好。

研究设计

采用离散选择实验。

方法

共邀请 178 名年龄≥50 岁的成年人使用六种疫苗属性在 HZ 疫苗接种方案之间进行选择。使用两个方程来计算参与者对疫苗的支付意愿和他们的预测选择概率。

结果

显著影响参与者疫苗选择的属性是更低的成本、更高的有效性、更少的副作用和周围环境中其他人的接种。

结论

改善医疗保险覆盖范围或降低 HZ 疫苗的成本将鼓励更多的人接种疫苗,从而减轻老年人的疾病负担。

相似文献

1
Factors influencing herpes zoster vaccination among older people in China: results from a discrete choice experiment.影响中国老年人带状疱疹疫苗接种的因素:一项离散选择实验的结果。
Public Health. 2023 Jul;220:33-34. doi: 10.1016/j.puhe.2023.04.025. Epub 2023 May 30.
2
Preferences and Willingness to Pay for Herpes Zoster Vaccination Among Chinese Adults: Discrete Choice Experiment.中国人对带状疱疹疫苗接种的偏好和支付意愿:离散选择实验。
JMIR Public Health Surveill. 2024 Aug 9;10:e51242. doi: 10.2196/51242.
3
Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment.美国 50 岁及以上成年人中带状疱疹疫苗接种的偏好:一项离散选择实验的结果。
Expert Rev Vaccines. 2021 Jun;20(6):729-741. doi: 10.1080/14760584.2021.1910502. Epub 2021 Jul 22.
4
A systematic review of the cost effectiveness of herpes zoster vaccination.带状疱疹疫苗成本效益的系统评价。
Pharmacoeconomics. 2013 Feb;31(2):125-36. doi: 10.1007/s40273-012-0020-7.
5
Public health impact of herpes zoster vaccination on older adults in Hong Kong.香港老年人接种带状疱疹疫苗的公共卫生影响。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2176065. doi: 10.1080/21645515.2023.2176065. Epub 2023 Feb 28.
6
Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines.免疫功能正常的老年人接种带状疱疹疫苗的成本效益:佐剂亚单位疫苗与减毒活疫苗的比较。
BMC Med. 2018 Dec 6;16(1):228. doi: 10.1186/s12916-018-1213-5.
7
Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults.非活佐剂重组带状疱疹疫苗对加拿大成年人的公共卫生影响和成本效益。
Appl Health Econ Health Policy. 2019 Oct;17(5):723-732. doi: 10.1007/s40258-019-00491-6.
8
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?在 5 个拉丁美洲国家为≥50 岁人群引入重组带状疱疹疫苗,其对公众健康的影响可能有多大?
Hum Vaccin Immunother. 2023 Dec 31;19(1):2164144. doi: 10.1080/21645515.2022.2164144. Epub 2023 Feb 23.
9
Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review.带状疱疹疫苗接种的成本效益:系统评价。
Pharmacoeconomics. 2019 Feb;37(2):169-200. doi: 10.1007/s40273-018-0735-1.
10
Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults.在中国成年人中,用含佐剂的带状疱疹亚单位疫苗进行具有成本效益的接种的最佳性别特定年龄。
PLoS One. 2019 Jan 4;14(1):e0210005. doi: 10.1371/journal.pone.0210005. eCollection 2019.

引用本文的文献

1
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review.健康经济学中离散选择实验的发展态势:一项系统综述
Pharmacoeconomics. 2025 May 21. doi: 10.1007/s40273-025-01495-y.
2
Patient preferences toward herpes zoster vaccination among individuals aged 50 years or older in South Korea: Findings from a discrete choice experiment.韩国50岁及以上人群对带状疱疹疫苗的偏好:离散选择实验的结果
Hum Vaccin Immunother. 2025 Dec;21(1):2469419. doi: 10.1080/21645515.2025.2469419. Epub 2025 Mar 10.
3
Willingness to pay for vaccines in China: A systematic review and single-arm Bayesian meta-analysis.
中国对疫苗的支付意愿:系统评价与单臂贝叶斯荟萃分析。
Hum Vaccin Immunother. 2025 Dec;21(1):2454076. doi: 10.1080/21645515.2025.2454076. Epub 2025 Feb 4.
4
Cost-Effectiveness Analysis of Herpes Zoster Vaccination in a Chinese Population: Recombinant Subunit Vaccine versus Live Attenuated Vaccine.中国人群中带状疱疹疫苗接种的成本效益分析:重组亚单位疫苗与减毒活疫苗对比
Vaccines (Basel). 2024 Aug 1;12(8):872. doi: 10.3390/vaccines12080872.
5
Preferences and Willingness to Pay for Herpes Zoster Vaccination Among Chinese Adults: Discrete Choice Experiment.中国人对带状疱疹疫苗接种的偏好和支付意愿:离散选择实验。
JMIR Public Health Surveill. 2024 Aug 9;10:e51242. doi: 10.2196/51242.
6
Development of a Prediction Model and Corresponding Scoring Table for Postherpetic Neuralgia Using Six Machine Learning Algorithms: A Retrospective Study.使用六种机器学习算法开发带状疱疹后神经痛预测模型及相应评分表:一项回顾性研究
Pain Ther. 2024 Aug;13(4):883-907. doi: 10.1007/s40122-024-00612-7. Epub 2024 Jun 4.